$2.04 Billion is the total value of Slate Path Capital LP's 14 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLF | Sell | SELECT SECTOR SPDR TRsbi int-finl | $286,184,000 | -54.6% | 12,060,000 | -55.5% | 14.00% | -26.9% |
| CHTR | CHARTER COMMUNICATIONS INC Ncl a | $245,490,000 | +13.7% | 750,000 | 0.0% | 12.01% | +83.0% | |
| ALLY | ALLY FINL INC | $211,839,000 | +6.9% | 10,420,000 | 0.0% | 10.36% | +72.0% | |
| TWTR | Buy | TWITTER INC | $196,443,000 | +217.6% | 13,140,000 | +246.2% | 9.61% | +411.0% |
| GDX | Buy | VANECK VECTORS ETF TRgold miners etf | $174,382,000 | +30.8% | 7,645,000 | +19.9% | 8.53% | +110.5% |
| AAP | Buy | ADVANCE AUTO PARTS INC | $161,603,000 | +9.2% | 1,090,000 | +24.6% | 7.91% | +75.8% |
| TIF | New | TIFFANY & CO NEW | $158,198,000 | – | 1,660,000 | +100.0% | 7.74% | – |
| TSO | TESORO CORP | $147,124,000 | -7.3% | 1,815,000 | 0.0% | 7.20% | +49.2% | |
| PODD | INSULET CORP | $122,807,000 | +14.4% | 2,850,000 | 0.0% | 6.01% | +84.0% | |
| X | Buy | UNITED STATES STL CORP NEW | $105,318,000 | +19.5% | 3,115,000 | +16.7% | 5.15% | +92.3% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $102,500,000 | +36.9% | 2,000,000 | 0.0% | 5.02% | +120.3% | |
| DXCM | New | DEXCOM INC | $94,855,000 | – | 1,119,500 | +100.0% | 4.64% | – |
| MDCO | New | MEDICINES CO | $33,252,000 | – | 680,000 | +100.0% | 1.63% | – |
| SSW | New | SEASPAN CORP | $3,881,000 | – | 560,000 | +100.0% | 0.19% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -475,000 | -100.0% | -0.20% | – |
| SKX | Exit | SKECHERS U S A INCcl a | $0 | – | -1,860,000 | -100.0% | -1.39% | – |
| GM | Exit | GENERAL MTRS CO | $0 | – | -5,650,000 | -100.0% | -5.98% | – |
| XLK | Exit | SELECT SECTOR SPDR TRput | $0 | – | -4,500,000 | -100.0% | -6.62% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -4,500,000 | -100.0% | -30.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
| ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
| UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
| NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
| VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
| PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
| CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
| BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
| MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
| MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
| Stitch Fix, Inc. | February 14, 2023 | ? | ? |
| Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
| Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
| 5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
| Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
| Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
| Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-01-13 |
| SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.